Panther Fusion GBS Assay

Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test

Diagenode

The following data is part of a premarket notification filed by Diagenode with the FDA for Panther Fusion Gbs Assay.

Pre-market Notification Details

Device IDK181156
510k NumberK181156
Device Name:Panther Fusion GBS Assay
ClassificationNucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test
Applicant Diagenode Rue Du Bois Saint Jean 3 Seraing,  BE 4102
ContactGeraldine Poncin
CorrespondentJinjie Hu
Axteria BioMed Consulting Inc. 8040 Cobble Creek Circle Potomac,  MD  20854
Product CodeNJR  
CFR Regulation Number866.3740 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2018-05-01
Decision Date2018-07-27
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.